Tag: CORO
Unvaccinated Have Highest SARS-CoV-2 Incidence, Hospitalization
Unvaccinated persons have higher rates of incidence, hospitalization during periods of delta, omicron predominance
Risk for Breakthrough SARS-CoV-2 Infection Lower With mRNA-1273
Risk for breakthrough infection and of 60-day hospitalization significantly lower for mRNA-1273 versus BNT162b2 vaccination
Remdesivir Offers Some Benefit for Hospitalized COVID-19 Patients
No difference seen for in-hospital mortality, but need for initiation of mechanical ventilation reduced with addition of remdesivir to standard care
SARS-CoV-2 Antibody Tests Should Not Be Used for Diagnosis
Related review shows that recent infection protected against symptomatic reinfection with the wild-type or alpha variant of SARS-CoV-2
Pfizer Will Ask FDA to Approve Its COVID-19 Vaccine for Children Under 5 Years
If approved, the two-shot regimen would become the first approved for use in children this young
FDA Gives Moderna COVID-19 Vaccine Full Approval
Vaccine, which has been available for the age group under emergency use authorization, will be marketed as Spikevax
‘Stealth’ Version of Omicron Variant No Cause for Alarm, Experts Say
New version of the variant does not appear to cause more severe disease, and vaccines are effective against it
Remdesivir May Benefit Adults Early in COVID-19 Course
Real-world data support the use of remdesivir for hospitalized COVID-19 patients receiving no oxygen or low-flow oxygen
Thrombosis, Thrombocytopenia Syndrome Up After Ad26.COV2.S
Reporting rates 3.83 per million vaccine doses for Ad26.COV2.S versus 0.00855 per million for mRNA-based vaccines
Neutralization Titers Against Omicron Up With mRNA-1273 Boost
After mRNA-1273 boost, neutralization titers against the omicron variant 20.0 times higher than than those at one month after second dose
